Healthcare

The healthcare sector remains one of the fastest growing parts of the global economy and one of the biggest challenges facing policy makers and the private sector. The cost of healthcare continues to outpace inflation in virtually every country in the world, and efforts at reform and cost containment make operating a commercial venture in the sector a continually dynamic enterprise. Despite the challenges, though, the sector holds great opportunities driven by the aging population in developed countries, increasing demand for sophisticated therapies and care systems in developing countries, rapidly advancing health technologies.

The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
Page 13/13
Category Tools

Philips Healthcare - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Philips Healthcare - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Krka, d. d., Novo mesto - Strategy and SWOT Report

December 2012 · MarketLine Krka, d. d., Novo mesto - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Amgen, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Amgen, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Recordati S.p.A. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Recordati S.p.A. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Celgene Corporation - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Celgene Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Molina Healthcare, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Molina Healthcare, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Universal Health Services, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Universal Health Services, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Virbac Corporation - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Virbac Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Highmark Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Highmark Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Align Technology, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Align Technology, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

LCA-Vision Inc. - Strategy and SWOT Report

December 2012 · MarketLine LCA-Vision Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Crucell N.V. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Crucell N.V. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Health Care Service Corporation - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Health Care Service Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

December 2012 · MarketLine Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Pharmaceuticals: Global Industry Almanac

December 2012 · MarketLine Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 2.199,00

Pharmaceuticals: Global Industry Guide

December 2012 · MarketLine Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 1.099,00

Pharmaceuticals - Global Group of Eight (G8) Industry Guide

November 2012 · MarketLine Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and ... € 1.099,00

Pharmaceuticals - Top 5 Emerging Markets Industry Guide

November 2012 · MarketLine Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). € 749,00

Pharmaceuticals - North America (NAFTA) Industry Guide

November 2012 · MarketLine Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. € 599,00

Pharmaceuticals: Global Industry Almanac

November 2012 · MarketLine Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 2.199,00

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

November 2012 · MarketLine Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on ... € 749,00

Pharmaceuticals - Scandinavia Industry Guide

November 2012 · MarketLine Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data ... € 599,00

Pharmaceuticals: Global Industry Guide

November 2012 · MarketLine Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 1.099,00
Options